Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD
暂无分享,去创建一个
E. Kerwin | R. Rodríguez-Roisín | L. Fabbri | S. Sethi | G. Ferguson | C. Reisner | S. Dwivedi | S. Spangenthal | Tracy L. Fischer | P. Darken | C. Orevillo | E. St Rose | M. Golden | J. Pearle